Evidence map›Paper›PMID 40694076›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2025

The visual quality of patients with myopia and presbyopia after ICL V4c implantation and FS-LASIK using monovision design.

Yong Ma, Yuhao Ye, Yiyong Xian, Lingling Niu, Wanru Shi, Xingtao Zhou, Jing Zhao

Abstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yong Ma *Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
Yuhao Ye *Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
Yiyong XianEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
Lingling NiuEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
Wanru ShiEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
Xingtao ZhouEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China. doctzhouxingtao@163.com.ORCID http://orcid.org/0000-0002-3465-1579
Jing ZhaoEye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China. zhaojing_med@163.com.

Funding

China Postdoctoral Science Foundation 2023M730626Healthy Young Talents Project of Shanghai Municipal Health Commission 2022YQ015National Natural Science Foundation of China 82271119National Natural Science Foundation of China 82304260Project of Shanghai Science and Technology 20410710100Project of Shanghai Science and Technology 21Y11909800Project of Shanghai Xuhui District Science and Technology 2020-015Shanghai Rising-Star Program 23QA1401000
6 · The paper itself

Abstract

backgroundLong-term visual quality of myopes with presbyopia was investigated after implantable collamer lens (ICL) V4c implantation and femtosecond laser-assisted in situ keratomileusis (FS-LASIK) surgery using a monovision design.

methodsFifty-eight patients (116 eyes) were enrolled and average final follow-up time was 55.38 ± 19.38 months. Routine ocular examinations (manifest refraction, axial length, and anterior segment biological parameters), were performed before and after the surgeries. Patients' objective visual quality was evaluated using contrast sensitivity (CS) parameters and signal-to-noise ratio (SNR), while subjective visual quality was assessed using a questionnaire.

resultsICL and FS-LASIK were successfully performed without complications in all subjects. Binocular visual acuity at near and middle distances remained unchanged; however, at far distances (0.05 ± 0.11 in the ICL group and 0.10 ± 0.23 in the FS-LASIK group, P = 0.02) difference was observed. The CS of dominant eyes were 8.57 ± 2.27 and 7.45 ± 2.68 in the ICL V4c and FS-LASIK groups, respectively (P = 0.550). Moreover, SNR was 5.41 ± 2.10 in the ICL V4c group and 8.00 ± 2.43 in the FS-LASIK group (P < 0.001). CS and visual acuity of the non-dominant eye showed positive correlations at near (B = 3.29, P = 0.037) and far distances (B = 6.649, P = 0.001); however, at moderate distances (B=-3.909, P = 0.023) a negative correlation occurred.

conclusionsBoth ICL V4c and FS-LASIK provided long-term safety and efficacy for binocular vision in patients with myopia and presbyopia. Correlation between the CS and visual quality of non-dominant eyes at different distances was observed. KEY MESSAGES: What is known Monovision design for refractive surgeries can effectively correct the refractiveerrors of myopia patients with presbyopia. Binocular imbalance exists in patients after refractive surgery. What is new The visual acuity of the non-dominant eyes at different distances was the mainfactor influencing binocular balance. Correlation between the contrast sensitivity and visual quality of non-dominanteyes at different distances was observed.

Indexed as

Keratomileusis, Laser In SituLasers, ExcimerLens Implantation, IntraocularMyopiaPhakic Intraocular LensesPresbyopiaRefraction, OcularVision, BinocularVisual AcuityAdultContrast SensitivityFemaleFollow-Up StudiesHumansMaleMiddle AgedContrast sensitivityFS-LASIKICL V4c implantationVisual quality

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.